CIK 0001599298
- Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 371979717
- Phone
- +1 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-16 | Zanganeh Maky Co-CEO & President | Purchase | +184,430 | $0.97 | $179K | 359,969 |
| 2022-08-16 | Zanganeh Maky Co-CEO & President | Purchase | +4,593,777 | $0.97 | $4.5M | 7,061,557 |
| 2022-08-16 | Zanganeh Maky Co-CEO & President | Purchase | +1,030,925 | $0.97 | $1000K | 3,135,466 |
| 2021-12-15 | Zanganeh Maky Chief Operating Officer | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-05-12 | Zanganeh Maky Chief Operating Officer | Purchase | +389,077 | $5.24 | $2.0M | 2,643,319 |
| 2020-11-22 | Zanganeh Maky Chief Operating Officer | Grant or award · Stock Option (right to buy) | +2,400,000 | 3,724,499 | ||
| 2020-11-11 | Zanganeh Maky Director | Grant or award · Stock Option (right to buy) | +200,000 | 1,321,177 | ||
| 2020-11-11 | Zanganeh Maky Director | Grant or award · Stock Option (right to buy) | +3,323 | 1,324,500 |
Page 1 of 1 · 8 trades